How do I manage nausea on a GLP-1 medication?

The dose schedule is the lever the label gives you

These medications are not started at their working dose. The escalation is deliberately slow, and that schedule is the main tolerability tool written into the labels themselves.

The recommended starting dosage of Zepbound for all indications is 2.5 mg injected subcutaneously once weekly for 4 weeks; the 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage. After 4 weeks at 2.5 mg, the Zepbound dosage is increased to 5 mg subcutaneously once weekly, and may thereafter be increased in 2.5 mg increments after at least 4 weeks on the current dose.

Semaglutide follows the same shape. Wegovy injection is escalated on a 4-week-per-step schedule: 0.25 mg once weekly for weeks 1-4, 0.5 mg for weeks 5-8, 1 mg for weeks 9-12, 1.7 mg for weeks 13-16, then a maintenance dose from week 17 onward. After 4 weeks on the 0.25 mg starting dosage, the OZEMPIC injection dosage is increased to 0.5 mg once weekly.

Tolerability is written into at least one escalation decision. For weight reduction in adults, the Wegovy injection maintenance dose is 1.7 mg or 2.4 mg once weekly, and may be increased to a maximum of 7.2 mg once weekly if further weight reduction is needed and the dose is tolerated. The label also contemplates a lower maintenance dose in one indication: for noncirrhotic MASH with moderate to advanced liver fibrosis, the Wegovy injection maintenance dose is 2.4 mg once weekly, which may be reduced to 1.7 mg once weekly if needed.

Here is the guardrail. None of that is yours to change on your own. Do not skip a dose to feel better, split a pen, or decide to stay at a lower step without telling the person who prescribed it. Message your prescriber, describe what you are feeling and when, and let them make the call. There is also a rule for doses you actually miss: if a Zepbound dose is missed, patients should administer it as soon as possible within 4 days (96 hours) after the missed dose; if more than 4 days have passed, the missed dose is skipped and the regular weekly schedule resumed.

One more thing the labels are explicit about: concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended. Stacking products is not a tolerability strategy.

Day-to-day ways to reduce GLP-1 nausea

The label gives you the escalation schedule. It does not tell you what to do on a Tuesday afternoon. These are standard supportive-care measures contributed by Elena Gizzi, MSN, RN — they are not drawn from the FDA labels in our sourced set, and they are comfort measures rather than a reason to delay telling your prescriber what you are feeling.

• Eat smaller meals. Stop eating when you first feel full rather than trying to finish the plate.
• Eat slowly. Give your stomach time to signal fullness.
• Choose bland, low-fat foods when you are nauseated — crackers, toast, rice, soup.
• Avoid greasy, high-fat, and very spicy foods, particularly around the time nausea is worst.
• Stay hydrated, but take fluids in smaller amounts if drinking a lot at once makes you feel worse. Water and foods with a high water content both count.
• Do not lie down immediately after eating.
• Get fresh air, or move gently. Light activity can sometimes take the edge off the feeling.

If these are not touching it, or you cannot keep fluids down, that is a message to your care team rather than something to manage at home.

What our sources do not tell you

We are not going to fill these in from memory. Our sourced set does not describe the time course of GLP-1 nausea — when it typically starts after initiation, whether it peaks and when, or how long it lasts after each dose increase. It does not describe how meal timing relative to injection day affects symptoms. It does not cover over-the-counter remedies or prescription antiemetics, their effectiveness, or their interactions with these medications. And it does not describe a general dose-hold or step-down protocol used for tolerability.

Those are the questions people actually type into a search bar, and we would rather leave a visible hole than publish a confident guess about a medication you are injecting into yourself. Each one is listed as a gap so a clinician-reviewed source can be added — which is how the day-to-day measures above got here.

Nausea that needs a clinician, not a coping strategy

Some abdominal symptoms are not ordinary nausea. The Zepbound label's Warnings and Precautions section covers risk of thyroid C-cell tumors, severe gastrointestinal adverse reactions, acute kidney injury due to volume depletion, acute gallbladder disease, acute pancreatitis, hypersensitivity reactions, hypoglycemia, diabetic retinopathy complications in patients with type 2 diabetes mellitus, pulmonary aspiration during general anesthesia or deep sedation, and never sharing a Zepbound KwikPen between patients. Wegovy's Warnings and Precautions include risk of thyroid C-cell tumors, acute pancreatitis, acute gallbladder disease, hypoglycemia, acute kidney injury due to volume depletion, severe gastrointestinal adverse reactions, hypersensitivity reactions, diabetic retinopathy complications in patients with type 2 diabetes, heart rate increase, and pulmonary aspiration during general anesthesia or deep sedation.

Pancreatitis carries a specific instruction. Acute pancreatitis has occurred in clinical trials with semaglutide; Wegovy should be discontinued promptly if pancreatitis is suspected and should not be restarted if pancreatitis is confirmed. Our sourced set does not describe what these conditions feel like symptom by symptom, so we are not going to give you a checklist of sensations. If your symptoms are severe, are not settling, or are keeping fluids down, contact a clinician the same day rather than waiting for your next scheduled contact. Separately, if you are unsure whether you should be on a GLP-1 at all, see who should not take a GLP-1 medication.

Form changes the instructions

Semaglutide exists as an injection and as a daily oral tablet. Tirzepatide, in our sourced set, does not. Zepbound is administered exclusively as a subcutaneous injection; the FDA label describes it only as 'injection, for subcutaneous use' and no oral dosage form of Zepbound is listed in the label.

The oral form has administration rules that the injection does not. Wegovy tablets are taken orally once daily on an empty stomach in the morning with up to 4 ounces of water; the patient must wait at least 30 minutes before eating food, drinking other beverages, or taking other oral medications. Wegovy tablets are escalated on a 30-day-per-step schedule: 1.5 mg once daily on days 1-30, 4 mg once daily on days 31-60, 9 mg once daily on days 61-90, then 25 mg once daily as the maintenance dose from day 91 onward. In OASIS 4, gastrointestinal adverse events were more common with oral semaglutide 25 mg than with placebo (74.0% versus 42.2%), in results published as of August 4, 2026.

What a supervised program changes

The practical problem with nausea is timing. It shows up on a Tuesday, and the next appointment is in three weeks.

A Measured patient's care team includes their provider, a Registered Dietitian, and a care coordinator, with unlimited messaging access. Measured states video is not required for medication consultations, and that medical evaluations and follow-up care are conducted asynchronously through secure, HIPAA-compliant messaging within the Measured patient portal. That means a symptom can be written down the day it happens.

General comfort measures are one thing; a plan built around your own history, medications and preferences is a dietitian's job. All dietitians on Measured's platform are Registered Dietitians (RDs) who have completed supervised clinical training and maintain required state licensure to provide nutrition counseling. Measured patients can schedule a 60-minute nutrition counseling appointment directly through the Measured portal, and Measured describes nutrition counseling appointments with a Registered Dietitian as an optional add-on to membership that is typically covered by insurance for most patients, as of August 5, 2026. Here is what to expect from a nutrition counseling appointment.

Dose decisions stay with the prescriber, and the prescriber has options in front of them. Measured prescribes FDA-approved GLP-1 medications and compounded alternatives, specifically semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), compounded alternatives when brand medications are unavailable, and oral medications including metformin, topiramate, and bupropion/naltrexone. Compounded medications are not reviewed or approved by the FDA for safety or effectiveness.

Coverage of any specific medication depends entirely on your own plan and its terms. Nothing here says a particular plan covers a particular drug.

This article is for general information and is not medical advice. It does not replace an evaluation by a licensed clinician who knows your history. Talk to your prescriber before changing any dose or adding any medication.